re: pan australia nominees becomes major stakehold Here they...

re: pan australia nominees becomes major stakehold Here they come:))

Top 20 Holders of Perpetual Exchangeable Resettable Listed Securities II as at 9 August 2005 of CBA:

http://www.commbank.com.au/shareholder/2005annualreport/shareholding_information_fr.asp

Top 20 Holdings of QAN as of 22/8/06

JP Morgan Nominees Australia Ltd 481,968,046 24.65
Westpac Custodian Nominees Ltd 327,049,506 16.7268
National Nominees Limited 239,422,337 12.2451
ANZ Nominees Limited 130,563,224 6.6776
Citicorp Nominees Pty Limited 85,760,116 4.3862
RBC Dexia Services Australia Nominees 39,054,984 1.9974
Cogent Nominees Pty Limited 37,196,068 1.9024
UBS Nominees Pty Ltd 21,299,328 1.0893
HSBC Custody Nominees 21,140,681 1.0812
Australian Reward Investment Alliance 18,451,627 0.9437
Woodross Nominees Pty Ltd 13,987,501 0.7154
AMP Life Limited 11,420,137 0.5841
Westpac Financial Services Ltd 8,427,723 0.431
Queensland Investment Corporation 6,713,335 0.3433
Pacific Custodians Pty Limited 5,807,393 0.297
Merrill Lynch (Australia) Nominees 5,591,349 0.286
Pan Australia Nominees Pty Limited 4,460,000 0.2281
Bond Street Custodians Limited 4,222,163 0.2159
Argo Investments Limited 3,749,302 0.1918
Victorian Workcover Authority 3,415,181 0.1747
__________________

LOL

Melrose quits Chemeq stake: "My generosity backfired"
20-December-06 by Mark Pownall

Rockingham-based veterinary pharmaceuticals manufacturer Chemeq Ltd has seen a 50 per cent jump in its share price following the announcement today that founder Graham Melrose had quit his stake in the company.

According to a substantial shareholder notice, Dr Melrose sold his 26 per cent holding in the company, clearing what was scene as an overhang in the market, resulting in a 12 cent rise in the share price to 24 cents.

Dr Melrose told WA Business News this afternoon that he was forced to quit the stake due to a loan agreement struck two years ago to raise $6.5 million to support the company. The lender had made the decision to sell due to the share price which has slumped in recent weeks, effectively severing his last major link with the company..

"For my equity to go in this way is very disappointing," Dr Melrose said.

"It has been 20 years of sacrifice and very hard work."

He said he still believed in the company.

"I would have to say the sale is not reflective of my estimate of the company, it has not been my decision."

"I think the technology of the company is well proven."

Dr Melrose said he took the loan through Victorian lender Primebroker to provide funding for the company when it was desperately needed.

"The loan was something that I never wished to take out and I did it purely to support the company," he said.

"My generosity has backfired."

However, Dr Melrose said, in hindsight, he would most likely take the same course of action.

The 25.2 million share stake was worth a fraction of the value from Chemeq's heyday in 2004. Then the stock peaked at about $5.50 a share before the company was rocked by overruns on the construction of its production facility and then faced a series of embarrassing disclosures.

Deutsche Securities Australia has acquired a 6 per cent stake for around $1 million.

Dr Melrose retired from the board in August.

In October the company faced another major hurdle when a major bond holder issued a default notice.

http://www.wabusinessnews.com.au/en-story.php?/1/47433/Melrose-quits-Chemeq-stake/dba